![Marco Studer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marco Studer
Operationeel Directeur bij Aebi & Co. AG Maschinenfabrik
Oorsprong van het eerstegraads netwerk van Marco Studer
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Aviation Works Ltd.
![]() Aviation Works Ltd. Miscellaneous Commercial ServicesCommercial Services Aviation Works Ltd. is a British company founded in 2018 that is inspired by aviation and medical research. The company's first product, Cordillera, is an update to the aircraft passenger emergency oxygen system and has received industry recognition.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marco Studer via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Morgan Stanley & Co. International Plc
![]() Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Investment Banks/Brokers | Analyst-Equity | |
IIG Istanbul Investment Group
![]() IIG Istanbul Investment Group Investment ManagersFinance IIG Istanbul Investment Group (IIG) is an independent private equity firm with headquarters in Istanbul, Turkey. The firm was founded in2015. | Investment Managers | President | |
Spiden AG
![]() Spiden AG Miscellaneous Commercial ServicesCommercial Services Spiden AG is a company based in Pfaffikon, Switzerland that aims to become the benchmark platform for longevity and preventative medicine. The Swiss company provides real-time biomarker and drug analysis to empower clinicians, patients, and healthy individuals in making more informed and timely decisions, and increase the safety and efficacy of medical treatments. Spiden has developed the world's first data generation platform to perform spectroscopic measurements of a wide range of biomarkers and drugs in blood. The company envisions a future where human blood can be continuously measured with an implant and become state-of-the-art to living a healthier and longer life, detecting diseases earlier, and helping to improve and personalize medical treatments. In the short term, Spiden intends to work with established industry players and create blood monitoring technology that can improve the safety and efficacy of treatments of the critically ill in clinical settings. The company was founded by Leo Grünstein and Ovunc Okyay in 2017, and Leo Grünstein has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder |
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Turkije | 2 |
Zwitserland | 2 |
Sectoraal
Finance | 3 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 3 |
Analyst-Equity | 1 |
President | 1 |
Founder | 1 |
Sterkste connecties
Insiders | |
---|---|
Ovunc Okyay | 4 |
Robert Andrew Boyle | 1 |
Timothy Wakeford | 1 |
- Beurs
- Insiders
- Marco Studer
- Bedrijfsconnecties